ESR1 and breast cancer: Engraftment rate for primary estrogen receptor positive (ER+) breast cancers was only 4–20% [63] whereas the engraftment rate for primary triple-negative breast cancer (TNBC) was 30–34% when transplanted subcutaneously, and 60–86% when transplanted orthotopically [63].